As of 11:31 AM on the 19th, Celltrion is trading at 306,000 KRW, up 0.66% from the previous day. This represents a 4.97% decline compared to July 23. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a net purchase of 15,914 shares of Celltrion, while institutions have a net sale of 10,000 shares, according to provisional data. Over the past five days, individual investors have net sold 636,969 shares, while foreigners and institutions have net bought 428,454 shares and 217,000 shares, respectively.

On August 10, Celltrion was a market topic for its "strong performance with record-high Q2 results."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing